Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the treatment of movement and neuropsychiatric disorders. DBS in select brain regions has provided therapeutic benefits for otherwise-treatment-resistant disorders such as Parkinson's disease, essential tremor, dystonia, chronic pain, major depression and obsessive–compulsive disorder (OCD). Despite the long history of DBS, its underlying principles and mechanisms are still not clear. DBS directly changes brain activity in a controlled manner, its effects are reversible (unlike those of lesioning techniques), and it is one of only a few neurosurgical methods that allow blinded studies.
North America is the largest sales place, with a sales market share nearly 51% in 2016. Following North America, Europe is the second largest sales place with the sales market share of 30%. China, Japan is also important sales regions for Deep Brain Stimulation Devices.
Deep Brain Stimulation Device market is mainly occupied by large companies, Sorin as the largest player in the market produced over 57% of Artificial Heart Lung Machine and made more than 59.6% of revenue share in 2016. MAQUET followed as second produced about 18.3% in 2016.
Through the above research we tend to believe that Medtronic is the most important player in the market and it will occupy a major share of the market with about 70%. The competition will become more intense, companies will play more and more attention to developing regions in the future. Most DBS systems have received CE mark in Europe and then received approval in the US. Frequent approvals by regulatory services boost the market growth. The rise in the number of products seeking approval may help the market grow at a rapid pace during the forecast period.
Market Analysis and Insights: Global Deep Brain Stimulation Devices Market
The global Deep Brain Stimulation Devices market was valued at US$ 1171.9 in 2020 and will reach US$ 2133.3 million by the end of 2027, growing at a CAGR of 10.5% during 2022-2027.
Global Deep Brain Stimulation Devices Scope and Market Size
The global Deep Brain Stimulation Devices market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Deep Brain Stimulation Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Single-channel DBS
Dual Channel DBS
Segment by Application
Parkinson's Disease
Essential Tremor
Dystonia
Others
The Deep Brain Stimulation Devices market is analysed and market size information is provided by regions (countries). Segment by Application, the Deep Brain Stimulation Devices market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Medtronic
Boston Scientific
Abbott
Beijing Pins
SceneRay
North America is the largest sales place, with a sales market share nearly 51% in 2016. Following North America, Europe is the second largest sales place with the sales market share of 30%. China, Japan is also important sales regions for Deep Brain Stimulation Devices.
Deep Brain Stimulation Device market is mainly occupied by large companies, Sorin as the largest player in the market produced over 57% of Artificial Heart Lung Machine and made more than 59.6% of revenue share in 2016. MAQUET followed as second produced about 18.3% in 2016.
Through the above research we tend to believe that Medtronic is the most important player in the market and it will occupy a major share of the market with about 70%. The competition will become more intense, companies will play more and more attention to developing regions in the future. Most DBS systems have received CE mark in Europe and then received approval in the US. Frequent approvals by regulatory services boost the market growth. The rise in the number of products seeking approval may help the market grow at a rapid pace during the forecast period.
Market Analysis and Insights: Global Deep Brain Stimulation Devices Market
The global Deep Brain Stimulation Devices market was valued at US$ 1171.9 in 2020 and will reach US$ 2133.3 million by the end of 2027, growing at a CAGR of 10.5% during 2022-2027.
Global Deep Brain Stimulation Devices Scope and Market Size
The global Deep Brain Stimulation Devices market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Deep Brain Stimulation Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Single-channel DBS
Dual Channel DBS
Segment by Application
Parkinson's Disease
Essential Tremor
Dystonia
Others
The Deep Brain Stimulation Devices market is analysed and market size information is provided by regions (countries). Segment by Application, the Deep Brain Stimulation Devices market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Medtronic
Boston Scientific
Abbott
Beijing Pins
SceneRay
Frequently Asked Questions
This market study covers the global and regional market with an
in-depth analysis of the
overall growth prospects...
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by
highlighting information on
different aspects including drivers, restraints...
